MIR210HG has been experimentally demonstrated to promote proliferation and invasion of tumor cells in hepatocellular carcinoma, non-small-cell lung cancer, breast cancer, cervical cancer, osteosarcoma, and other tumors. The gene discussed is MIR210HG; the disease is neoplasm.